Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Cellulose (China)
- ·The full record, as it builds
Funding rounds
No funding rounds for Cellulose (China) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cellulose (China)
Developer of bacterial cellulose intended for biomedical applications. The company is committed to the industrial application of green and environmentally friendly bacterial cellulose, and has deployed in multiple fields such as medical dressings, biomedical materials, and cosmetics, permitting to expand the research and development of bio-enzyme technology.
- Sector
- Healthcare
- HQ
- Tianjin, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Cellulose (China) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cellulose (China) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cellulose (China) in its N-PORT filings yet. We sweep new filings monthly.